Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Recurrent or Persistent Metastatic Colorectal Cancer

NCT00023933 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

NIH

Sponsor class

Conditions

Adenocarcinoma of the Colon
Adenocarcinoma of the Rectum
Recurrent Colon Cancer
Recurrent Rectal Cancer
Stage IV Colon Cancer
Stage IV Rectal Cancer

Interventions

DRUG: iodine I 131 monoclonal antibody CC49-deltaCH2

Sponsor

National Cancer Institute (NCI)